Form 4: CME Group Director Bryan Durkin Acquires Shares Under Stock Plan

CME Group Inc. Director Bryan T. Durkin acquired 532 shares of Common Stock Class A at a price of $273.03 per share, increasing his beneficial ownership to 47,207 shares, as part of the company's Director Stock Plan.

Summary

• Bryan T. Durkin, a Director of CME Group Inc., acquired 532 shares of Common Stock Class A.
• The acquisition occurred on June 25, 2025, at a price of $273.03 per share.
• This transaction was a grant made pursuant to the CME Group Director Stock Plan, as amended and restated.
• Following this acquisition, Mr. Durkin beneficially owns 47,207 shares of CME Group Inc. Common Stock Class A.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even if a grant, generally signals confidence in the company's future performance and aligns management interests with shareholders.

Positives

• Director Bryan T. Durkin increased his stake in CME Group Inc. by acquiring 532 shares, demonstrating continued alignment with shareholder interests.
• The acquisition was part of the CME Group Director Stock Plan, indicating a structured compensation or incentive program for directors.

Future Outlook

N/A

Industry Context

N/A

Related Party Transactions

• Acquisition of 532 shares of Common Stock Class A by Director Bryan T. Durkin from CME Group Inc. at $273.03 per share, pursuant to the CME Group Director Stock Plan.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholders due to increased equity ownership.

Key Dates

Keywords

CME Group, CME, Form 4, insider transaction, stock acquisition, director compensation, equity plan, Bryan T. Durkin